Home > Education > Recorded education > Grand Rounds > JHCH Paediatric > 2025

Can Cancer Genetics Help?

Previous Years: 2024 | Current

25 February 2025

Dr Luke Walker Pediatric Oncology Fellow, JHH

Dr Noemi Fuentes Bolanos Pediatric Oncologist and Clinical Geneticist Kids Cancer Centre, Sydney Children's Hospital

Associate Professor Kathy Tucker Clinical Cancer Geneticist Hereditary Cancer Centre, Prince of Wales Hospital

UpToDate logo Treatment of adrenocortical carcinoma

UpToDate logo Clinical presentation and evaluation of adrenocortical tumors

Open Access logo The European Society for Pediatric Onocology Adrenocortical tumors in children and adolescents V.8, (nd)

Open Access logo St. Jude Children's Research Hospital Adrenocortical Tumor Treatment

Open Access logoLee, M., Lui, A.C.Y., Chan, J.C.K. et al. Revealing parental mosaicism: the hidden answer to the recurrence of apparent de novo variants. Hum Genomics 17, 91 (2023). https://doi.org/10.1186/s40246-023-00535-y

Open Access logoAchatz, Maria Isabel, and Gerard P Zambetti. The Inherited p53 Mutation in the Brazilian Population. old Spring Harbor perspectives in medicine vol. 6,12 a026195. 1 Dec. 2016, doi:10.1101/cshperspect.a026195

Open Access logo Li-Fraumeni Syndrome Association Criteria for LFS

Open Access logo Wang, H., Guo, M., Wei, H. et al.Targeting p53 pathways: mechanisms, structures and advances in therapy. Sig Transduct Target Ther 8, 92 (2023). https://doi.org/10.1038/s41392-023-01347-1

Open Access logo EviQ Facts for people and families with a faulty TP53 gene (Li-Fraumeni syndrome)

Open Access logo Colgan JN, Fuentes-Bolanos NA, Barbaric D, Dalla-Pozza L, Mitchell R, Samarasinghe S, et al.Scylla and Charybdis: Unpalatable choices in managing hypodiploid acute lymphoblastic leukemia. EJC Paediatric Oncology. 2023;2:100133.

Open Access logo Fortuno, Cristina et al.Cancer Risks Associated With TP53 Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome Spectrum. JCO precision oncology vol. 8 (2024): e2300453. doi:10.1200/PO.23.00453

Open Access logo FVillani, Anita et al.Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.The Lancet. Oncology vol. 17,9 (2016): 1295-305. doi:10.1016/S1470-2045(16)30249-2

Back